SU5205
Code | Size | Price |
---|
TAR-T3566-25mg | 25mg | £94.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T3566-1mL | 1 mL * 10 mM (in DMSO) | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
SU 5205 is a VEGFR2 inhibitor.
CAS:
3476-86-6
Formula:
C15H10FNO
Molecular Weight:
239.249
Pathway:
Tyrosine Kinase/Adaptors; Angiogenesis
Purity:
0.9968
SMILES:
Fc1ccc(C=C2C(=O)Nc3ccccc23)cc1
Target:
VEGFR
References
Tian XF, et al. PACE4 regulates apoptosis in human pancreatic cancer Panc 1 cells via the mitochondrial signaling pathway. Mol Med Rep. 2016 Dec;14(6):5205-5210.